Krystal Biotech's VYJUVEK sees strong growth with $1B+ 2025 sales forecast. Check out why I rate KRYS as a Strong Buy and my ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month data on the first three adult OPGx-LCA5 patients to be pr ...

First patient dosed in the pediatric cohort of the Phase 1/2 trial of OPGx-LCA5; initial data on the cohort anticipated by Q3 2025New 12-month ...

Regeneron Pharmaceuticals' fourth quarter results beat my and Wall Street analysts' expectations. See why REGN stock is a top ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established. That is the ...

You’re not alone if you struggle to swallow a pill that could rival a S$1 coin. Okay, we exaggerate but have you seen the size of some supplement tablets? Or you often end up with a wet face when ...

The Holy Knights are the main enemies in the Elbaf arc, aiming to take control of the country. Shamrock has called for a third Holy Knight, signaling a potential major battle ahead in Aurust Castle.

It’s been a minute since Lifehacker looked at the slang of Generation Z—long enough that Generation Alpha has had time ... Green fn: An interjection one might used when someone does something ...

It picked up directly after the events of the season one finale cliffhanger, with the synopsis teasing more trouble in store for Owen and co. The official synopsis reads: ‘Season two of The ...

As Chinese AI startup DeepSeek draws attention for open-source AI models that it says are cheaper than the competition while providing similar or better performance, AI chip king Nvidia’s stock ...

Protheragen launches a full spectrum of ophthalmic drug preclinical R&D services to streamline the complex process of developing effective therapies for eye diseases. Protheragen, a reputable ...